Logo image
NMOSD acute attack: Understanding, treatment and innovative treatment prospect
Journal article   Peer reviewed

NMOSD acute attack: Understanding, treatment and innovative treatment prospect

X. Ma, A.G. Kermode, X. Hu and W. Qiu
Journal of Neuroimmunology, Vol.348, Art. 577387
2020
url
Link to Published Version *Subscription may be requiredView

Abstract

Neuromyelitis optica spectrum disorder (NMOSD) is a group of severe inflammatory demyelinating disorders of the central nervous system that involves the optic nerve and spinal cord. Currently the therapeutic options for an acute attack in NMOSD are limited and rarely characterized in clinical studies. This review discussed the overall characteristics of acute attack of NMOSD, related risk factor, prognosis and management. Considering the huge unmet needs and the emergence of new therapeutic targets, we also reviewed innovative treatments that might alleviate attack damage, along with the challenges to evaluate new drug for acute attack in NMOSD.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.203 Neuromuscular Disorders
1.203.147 Multiple Sclerosis
Web Of Science research areas
Immunology
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image